Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Xeris Biopharma Holdings, Inc. Common Stock (XERS) a Joel Greenblatt Stock?
Low Magic Formula score — expensive, low ROIC, or both.
0/100
FNot a fit
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to XERS
EBIT/EV yield ≥ 10%
key—
ROIC ≥ 25%
key-13.3%
EV/EBIT ≤ 12
-49.8x
Gross margin ≥ 30%
83.5%
How XERS Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.36B
P/E (TTM)
92.7x
ROIC (TTM)
12.84%
Gross margin
81.59%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is XERS's Joel Greenblatt fit score?
XERS scores 0/100 on our Joel Greenblatt fit engine — grade F. Low Magic Formula score — expensive, low ROIC, or both.
Does Joel Greenblatt actually own XERS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends XERS.
How often is this score updated?
XERS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends XERS.